Positrigo Launches BrainPET Accelerator Program in U.S.

Feb. 19, 2026 — Positrigo, a Swiss based company developing nuclear medical devices to advance functional brain imaging, has launched its  BrainPET Accelerator Program, a new initiative designed to enable neurology practices across the United States to access advanced brain PET imaging directly within their offices.

The BrainPET Accelerator Program removes traditional barriers to Positron Emission Tomography (PET) adoption by offering neurologists a streamlined, comprehensive pathway to implement advanced brain PET imaging at the point-of-care. By combining Positrigo’s compact, cost-efficient brain PET technology with operational and clinical support, the program empowers neurology practices to enhance diagnostic confidence and patient experience without relying on large hospital imaging departments.

“Brain PET imaging has long been underutilized due to its complexity, cost, and dependence on centralized facilities,” says Dr. Jannis Fischer, CEO and co-founder of Positrigo. “With the BrainPET Accelerator Program, Positrigo is pioneering a fundamental shift in how brain PET is delivered – bringing this powerful modality directly to neurologists and their patients at the point-of-care. Our goal is to make advanced brain imaging more accessible, practical, and impactful in everyday clinical practice.”

The BrainPET Accelerator Program is particularly suited for practices focused on neurodegenerative diseases, cognitive disorders, and other neurological conditions where advanced functional imaging can play a critical role in diagnosis and disease management.

With this launch, Positrigo continues its mission to transform brain imaging by making dedicated brain PET more accessible, scalable, and aligned with the needs of modern neurology care.

For more information visit https://brainpetaccelerator.positrigo.com/home

The BrainPET Accelerator Program

The BrainPET Accelerator is a comprehensive model where the neurology practice receives a ready-to-operate brain PET capability, with minimal internal effort beyond routine clinical operations. The program is customized to each neurology office but typically includes:

• Delivery and installation of a dedicated brain-PET NeuroLF system (hardware + software), properly configured and commissioned.
• Support for radiotracer procurement, supply or logistics — i.e., ensuring the needed radioactive tracers (e.g. for amyloid, tau, FDG, etc.) are available on demand without the clinic itself needing to run a cyclotron or radiochemistry lab.
• Reimbursement & Revenue Cycle Support
• Regulatory and licensing support: help obtaining/maintaining a radioactive materials license (or equivalent), radiation-safety compliance, personnel training, QA/QC.
• Operational workflows: patient scheduling, injection, scan acquisition, data reconstruction, image processing, reporting.
• Reading and interpretation: access to trained nuclear-medicine/radiology experts for image reading, quantification, and report generation.
• Maintenance, quality assurance, and ongoing service support (equipment maintenance, software updates, tracer coordination, compliance, etc.).

In short: a bundled, end-to-end brain-PET service that enables a neurology office to offer brain PET imaging without building major infrastructure in-house.